Clin2
NCT07088757Likely a fitRecruiting

Low-Dose vs Standard-Dose Indomethacin for Pancreatitis Prevention After ERCP

Post-ERCP Pancreatitis

Part of Digestive system clinical trials.

This study compares a low dose of indomethacin (a pain reliever) with the standard dose to see if it works just as well for preventing pancreatitis (inflammation of the pancreas) after an ERCP procedure. It may reduce side effects while still protecting your pancreas.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
1,366 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • You are scheduled to have an ERCP procedure (a scope to look at bile ducts).
  • You are not allergic to NSAIDs (like ibuprofen or aspirin).
  • You have not taken any NSAID in the week before ERCP.
  • You do not have recent stomach bleeding, kidney problems, or a bleeding disorder.
  • You do not have acute pancreatitis (sudden severe pancreas inflammation) within the last 3 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07247682Not yet recruiting· Phase 4
Higher doses of rectal indomethacin to prevent post-ERCP pancreatitis

This study tests giving indomethacin (a type of anti-inflammatory medicine) through the rectum in different doses to people having an ERCP (a procedure to look at bile and pancreas tubes), aiming to prevent a common complication called post-ERCP pancreatitis (inflammation of the pancreas). You may join if you are at high risk for this complication and meet the other health requirements.

Hefei, Anhui
NCT03713879Recruiting· Phase 3
Indomethacin vs pancreatic stent to prevent post-ERCP pancreatitis

This study compares indomethacin (an anti-inflammatory medicine) against using a temporary pancreatic stent to prevent pancreatitis after an ERCP procedure. It may help you lower the chance of painful inflammation of the pancreas after ERCP.

Xi'an, Shaanxi
NCT07661498Not yet recruiting· Phase 4
Indomethacin to prevent complications after ERCP

This study tests whether a rectal dose of indomethacin (an anti-inflammatory drug) can help prevent complications after an ERCP. It is for people who have already had a sphincterotomy and are having another ERCP to treat bile duct issues.

San Francisco, California
NCT07776561Recruiting
Short-stay IV fluids to prevent pancreatitis after ERCP

This trial tests whether giving extra IV fluids before, during, and after an ERCP procedure can help prevent a common complication called post-ERCP pancreatitis (inflammation of the pancreas). If you are scheduled for an ERCP, you may be eligible to participate.

Westmead, New South Wales
NCT07071441Recruiting
Indomethacin vs Diclofenac before ERCP to prevent pancreatitis

This study compares two common NSAID medications (indomethacin and diclofenac) given before an ERCP procedure to see if one is better at preventing pancreatitis, a common complication. If you are having an ERCP and meet the health criteria, you may be able to join.

Beijing, Beijing Municipality
NCT07826026Not yet recruiting
Medicine and ice water to prevent post-ERCP pancreatitis

This study tests whether adding ice water irrigation to standard rectal indomethacin reduces the risk of inflammation of the pancreas after ERCP, a procedure that examines the bile and pancreatic ducts. It may help prevent a painful complication.

Hear when a new Post-ERCP Pancreatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.